Diabetic Neuropathy Market - Industry Growth, Drivers, Restraints, Emerging Trends and New Technologies Research upto 2019

Diabetic neuropathy is a neurological disorder associated with diabetes mellitus. The disorder affects all peripheral nerves including autonomic nervous system, pain fibers, and motor neurons. According to World Health Organization (WHO) approximately 350 million people worldwide suffer from diabetes and 80% of them live in low and middle income countries.

Download Exclusive Sample of this Report: http://bit.ly/2ec16qi

Furthermore diabetic neuropathy affects 50% of the diabetic patients as per the data. Diabetes thus remains a burning issue in healthcare sector. Though symptoms of the disorder vary according to the nerves affected, common symptoms are abnormal sensations to body parts, erectile dysfunction, loss of control over bladder, dizziness, muscle weakness, intense pain, speech impairment and others.

Total cure for diabetic neuropathy does not exist, but therapeutic treatment can manage the related symptoms. Following therapies can be used for Diabetic neuropathy treatment:

Drugs

-Antispasmodic
-Detail2
-Antidepressant

Radio therapy

-Transcutaneous Electric Nerve Stimulation (TENS)
-Physiotherapy

The therapies can be directed to the symptoms of the disorder or to control diabetes itself. With the advances in technology, wearable devices have assisted in effectively treating the neuropathy pain. These devices use electric current to block the transmission of pain signals. The treatment is noninvasive, and has minimal side effects as compared to drug treatment.

Diabetes is a growing concern in many countries, especially developing economies which concentrate around 80% of the diabetes population. Currently North America and Europe are the major markets for diabetic neuropathy market owing to the advanced medical services and concentration of market leading companies. Asia Pacific will be most lucrative market in the future with India, Japan and China being main point of focus. There need an increased awareness about the available therapies in the developing economies.

Browse Research Report: http://bit.ly/2eAluUy

Commonly prescribed drugs for diabetic neuropathy are Lyrica, Carbatrol, Neurontin, Pamelor and Cymbalta to a name a few; major players being Pfizer, Glaxo Smith Kline Johnson & Johnson and Eli Lilly. For devices, NeuroMetrix is a significant player through the launch of Sensus which is an FDA approved TENS device for pain management.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.